Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2001 1
2002 1
2004 1
2006 1
2007 2
2008 6
2009 6
2010 5
2011 1
2012 1
2013 5
2014 3
2015 1
2016 1
2017 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Ocular neovascularization.
Campochiaro PA. Campochiaro PA. J Mol Med (Berl). 2013 Mar;91(3):311-21. doi: 10.1007/s00109-013-0993-5. Epub 2013 Jan 18. J Mol Med (Berl). 2013. PMID: 23329331 Free PMC article. Review.
MicroRNAs regulate ocular neovascularization.
Shen J, Yang X, Xie B, Chen Y, Swaim M, Hackett SF, Campochiaro PA. Shen J, et al. Mol Ther. 2008 Jul;16(7):1208-16. doi: 10.1038/mt.2008.104. Epub 2008 May 20. Mol Ther. 2008. PMID: 18500251 Free PMC article.
Trans-scleral delivery of antiangiogenic proteins.
Demetriades AM, Deering T, Liu H, Lu L, Gehlbach P, Packer JD, Mac Gabhann F, Popel AS, Wei LL, Campochiaro PA. Demetriades AM, et al. J Ocul Pharmacol Ther. 2008 Feb;24(1):70-9. doi: 10.1089/jop.2007.0061. J Ocul Pharmacol Ther. 2008. PMID: 18370877
Topical mecamylamine for diabetic macular edema.
Campochiaro PA, Shah SM, Hafiz G, Heier JS, Lit ES, Zimmer-Galler I, Channa R, Nguyen QD, Syed B, Do DV, Lu L, Monk J, Cooke JP, Kengatharan MK, Hsu HH. Campochiaro PA, et al. Am J Ophthalmol. 2010 May;149(5):839-51.e1. doi: 10.1016/j.ajo.2009.12.005. Epub 2010 Feb 26. Am J Ophthalmol. 2010. PMID: 20189159 Free PMC article. Clinical Trial.
Sustained delivery of a HIF-1 antagonist for ocular neovascularization.
Iwase T, Fu J, Yoshida T, Muramatsu D, Miki A, Hashida N, Lu L, Oveson B, Lima e Silva R, Seidel C, Yang M, Connelly S, Shen J, Han B, Wu M, Semenza GL, Hanes J, Campochiaro PA. Iwase T, et al. J Control Release. 2013 Dec 28;172(3):625-33. doi: 10.1016/j.jconrel.2013.10.008. Epub 2013 Oct 12. J Control Release. 2013. PMID: 24126220 Free PMC article.
Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature.
Shen J, Frye M, Lee BL, Reinardy JL, McClung JM, Ding K, Kojima M, Xia H, Seidel C, Lima e Silva R, Dong A, Hackett SF, Wang J, Howard BW, Vestweber D, Kontos CD, Peters KG, Campochiaro PA. Shen J, et al. J Clin Invest. 2014 Oct;124(10):4564-76. doi: 10.1172/JCI74527. Epub 2014 Sep 2. J Clin Invest. 2014. PMID: 25180601 Free PMC article.
35 results